Remove trial restrictions ▶ Start for $1

Serving leading biopharmaceutical companies globally:

Dow
McKesson
Colorcon
AstraZeneca
Baxter
Medtronic

Last Updated: May 29, 2023

Rubicon Company Profile


✉ Email this page to a colleague

« Back to Dashboard

▶ Start for $1
Remove trial restrictions


What is the competitive landscape for RUBICON, and what generic and branded alternatives to RUBICON drugs are available?

RUBICON has forty-six approved drugs.

There is one tentative approval on RUBICON drugs.

Summary for Rubicon
US Patents:0
Tradenames:41
Ingredients:41
NDAs:46

Drugs and US Patents for Rubicon

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Rubicon PANTOPRAZOLE SODIUM pantoprazole sodium TABLET, DELAYED RELEASE;ORAL 090807-001 May 2, 2012 AB RX No No ⤷  Try a Trial ⤷  Try a Trial
Rubicon PRIMIDONE primidone TABLET;ORAL 214896-002 Jun 28, 2022 AB RX No No ⤷  Try a Trial ⤷  Try a Trial
Rubicon BISOPROLOL FUMARATE bisoprolol fumarate TABLET;ORAL 075643-002 Nov 16, 2000 AB RX No No ⤷  Try a Trial ⤷  Try a Trial
Rubicon LEVOFLOXACIN levofloxacin SOLUTION/DROPS;OPHTHALMIC 078282-001 Dec 20, 2010 DISCN No No ⤷  Try a Trial ⤷  Try a Trial
Rubicon TRIAMTERENE AND HYDROCHLOROTHIAZIDE hydrochlorothiazide; triamterene TABLET;ORAL 216211-001 Feb 23, 2022 AB RX No No ⤷  Try a Trial ⤷  Try a Trial
Rubicon ISOSORBIDE DINITRATE isosorbide dinitrate TABLET;ORAL 215723-002 Jul 8, 2022 AB RX No No ⤷  Try a Trial ⤷  Try a Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Mallinckrodt
Johnson and Johnson
Colorcon
Baxter
McKinsey
McKesson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.